MAXCYTE, INC. (MXCT) Form 8-K Material Events
MAXCYTE, INC. (MXCT) is a publicly traded company on the Nasdaq, categorized under SIC 8731 (Services-Commercial Physical & Biological Research). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MXCT
CIK: 1287098
Exchange: Nasdaq
SIC 8731: Services-Commercial Physical & Biological Research
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CohnReznick LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerRobert Ryan
Audit LocationTysons, Virginia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D | 2026-10-15 | — | SCHEDULE 13D Filing | 0001544204-26-000009 | View SEC Doc Filr Page |
| 8-K | 2026-10-14 | 2026-10-14 | FORM 8-K | 0001104659-26-115745 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001104659-26-095971 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001104659-26-094886 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-04 | — | SCHEDULE 13D Filing | 0001486180-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0002012383-26-002825 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003056 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003055 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003054 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003053 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003052 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003051 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003050 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003049 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0001104659-26-075211 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-10 | 8-K | 0001104659-26-074594 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-14 | — | SCHEDULE 13D Filing | 0001486180-26-000002 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001104659-26-060290 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001104659-26-059399 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001140361-26-017847 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFA 14A | 0001140361-26-017845 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-17 | DEF 14A | 0001140361-26-017844 | View SEC Doc Filr Page |
| 4 | 2026-04-17 | 2026-04-15 | 4 Filing | 0000905148-26-001718 | View SEC Doc Filr Page |
| S-8 | 2026-04-15 | — | FORM S-8 | 0001104659-26-043814 | View SEC Doc Filr Page |
| 4 | 2026-04-10 | 2026-03-30 | 4 Filing | 0000905148-26-001644 | View SEC Doc Filr Page |